Self-immolative nanosensitizer for glutathione depletion- assisted sonodynamic therapy

Theranostics. 2022 Oct 24;12(17):7465-7475. doi: 10.7150/thno.75007. eCollection 2022.

Abstract

Background: Despite remarkable advances in sonodynamic therapy (SDT) of cancer, the low reactive oxygen species (ROS) quantum yield of the sonosensitizer remains a critical concern in glutathione (GSH)-overexpressing cancer cells. Methods: For enhanced SDT, we report hydrophilized self-immolative polymer (SIP)-decorated TiO2 nanoparticles (HSIPT-NPs) to achieve on-demand GSH depletion and ROS generation. Results: Upon intracellular delivery of HSIPT-NPs into hydrogen peroxide-rich cancer cells, SIP is degraded through electron transfer to produce GSH-depleting quinone methide, reprogramming GSH high cancer cells into GSH low phenotype. In the presence of ultrasound, compared to conventional TiO2 NPs, HSIPT-NPs induce significantly higher oxidative stress to cancer cells by incapacitating their antioxidant effects. SDT with HSIPT-NPs effectively inhibit tumor growth in mice via the synergistic effects of GSH depletion and ROS generation. Conclusion: On the basis of their ability to reprogram cancer cells, HSIPT-NPs offer considerable potential as a nanosensitizer for enhanced SDT.

Keywords: TiO2 nanoparticles; glutathione; reactive oxygen species; self-immolative polymer; sonodynamic therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / pharmacology
  • Glutathione / metabolism
  • Mice
  • Nanoparticles*
  • Neoplasms*
  • Reactive Oxygen Species / metabolism

Substances

  • Reactive Oxygen Species
  • titanium dioxide
  • Glutathione
  • Antioxidants